Sun Pharma Adv Resrc Financials
NSE: SPARC | BSE: 532872
₹203.27
As on 08-Sep-2026IST
Market cap
₹6,537 Cr
Revenue (TTM)
₹1,909 Cr
P/E Ratio
4.1
P/B Ratio
5
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
1,909.45
|
1,879.17
|
71.77
|
75.55
|
238.78
|
--
|
|||||
|
Total Income
|
1,934.92
|
1,890.12
|
73.56
|
105.01
|
249.66
|
--
|
|||||
|
Total Expenditure
|
292.61
|
280.40
|
394.90
|
477.64
|
452.84
|
--
|
|||||
|
EBITDA
|
1,616.84
|
1,598.76
|
-323.14
|
-402.10
|
-214.06
|
--
|
|||||
|
Depreciation
|
9.73
|
10.21
|
12.39
|
12.51
|
11.77
|
--
|
|||||
|
EBIT
|
1,607.11
|
1,588.56
|
-335.53
|
-414.61
|
-225.83
|
--
|
|||||
|
Interest
|
36.07
|
34.13
|
9.04
|
1.69
|
7.63
|
--
|
|||||
|
Other Income
|
25.47
|
10.95
|
1.79
|
29.47
|
10.88
|
--
|
|||||
|
Exceptional Items
|
-12.36
|
-12.36
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
1,584.15
|
1,553.01
|
-342.78
|
-386.83
|
-222.58
|
--
|
|||||
|
Provision for Tax
|
-0.14
|
-0.19
|
-0.27
|
0.38
|
--
|
--
|
|||||
|
Profit after Tax
|
1,584.29
|
1,553.20
|
-342.51
|
-387.21
|
-222.58
|
--
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
1,584.29
|
1,553.20
|
-342.51
|
-387.21
|
-222.58
|
--
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,338.82
|
1,338.83
|
-216.95
|
125.76
|
512.78
|
--
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
77.95
|
75.68
|
175.93
|
122.97
|
138.41
|
--
|
|||||
|
Current Liabilities
|
754.09
|
754.11
|
374.24
|
265.06
|
178.95
|
--
|
|||||
|
Total Liabilities
|
2,170.86
|
2,170.88
|
335.53
|
515.04
|
830.13
|
--
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
159.29
|
306.18
|
307.03
|
244.39
|
375.16
|
--
|
|||||
|
Current Assets
|
1,862.42
|
1,862.43
|
26.20
|
269.39
|
454.96
|
--
|
|||||
|
Total Assets
|
2,170.86
|
2,170.88
|
335.53
|
515.04
|
830.13
|
--
|
|||||
|
Total Debt*
|
--
|
556.14
|
258.19
|
47.00
|
0.05
|
--
|
|||||
|
Net Current Assets
|
1,108.33
|
1,108.32
|
-348.04
|
4.33
|
276.02
|
--
|
|||||
|
Contingent Liabilities
|
--
|
84.74
|
84.80
|
83.57
|
83.57
|
--
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-238.78
|
-360.29
|
-429.19
|
-69.12
|
--
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-23.50
|
157.66
|
391.53
|
-548.28
|
--
|
|||||
|
Cash from Financing Activities
|
--
|
261.39
|
199.26
|
42.41
|
616.76
|
--
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-0.89
|
-3.38
|
4.74
|
-0.64
|
--
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
49.20
|
47.86
|
-10.55
|
-11.93
|
-6.86
|
--
|
|||||
|
Cash EPS (₹)
|
48.82
|
48.17
|
-10.17
|
-11.55
|
-6.50
|
--
|
|||||
|
Adjusted Book Value (₹)
|
40.62
|
41.25
|
-6.69
|
3.88
|
15.80
|
--
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
-7.36
|
-11.10
|
-13.22
|
-2.13
|
--
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
-10.01
|
-11.93
|
-13.21
|
-2.62
|
--
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
163.94
|
-311.92
|
-112.35
|
-41.91
|
--
|
|||||
|
ROE (%)
|
--
|
276.89
|
--
|
-121.28
|
-43.41
|
--
|
|||||
|
ROA (%)
|
126.42
|
124.17
|
-80.88
|
-57.63
|
-26.81
|
--
|
|||||
|
EBIT Margin (%)
|
84.17
|
84.54
|
-467.54
|
-548.82
|
-94.57
|
--
|
|||||
|
Net Margin (%)
|
81.88
|
82.17
|
-465.64
|
-368.72
|
-89.16
|
--
|
|||||
|
Cash Profit Margin (%)
|
0.00
|
83.20
|
-459.99
|
-496.00
|
-88.29
|
--
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
2,855.80
|
2,518.47
|
-5.00
|
-68.36
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
647.03
|
573.44
|
19.07
|
-83.60
|
--
|
--
|
|||||
|
Net Profit Growth (%)
|
631.12
|
553.48
|
11.55
|
-73.96
|
--
|
--
|
|||||
|
EPS Growth (%)
|
627.01
|
553.48
|
11.55
|
-73.96
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
--
|
717.12
|
-272.52
|
-75.48
|
--
|
--
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
4.13
|
2.39
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
4.96
|
2.78
|
-22.14
|
95.47
|
11.36
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
4.32
|
2.66
|
-15.74
|
-31.93
|
-28.11
|
--
|
|||||
|
Close Price (₹)
|
234.75
|
114.89
|
147.91
|
368.30
|
179.35
|
--
|
|||||
|
High Price (₹)
|
253.17
|
204.40
|
474.00
|
423.60
|
305.85
|
--
|
|||||
|
Low Price (₹)
|
108.00
|
108.00
|
109.20
|
173.55
|
160.50
|
--
|
|||||
|
Market Cap (₹ Cr)
|
6,537.49
|
3,719.06
|
4,803.05
|
12,005.98
|
5,823.68
|
--
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.42
|
-1.19
|
0.37
|
0.00
|
--
|
|||||
|
Short term debt to equity ratio
|
--
|
0.42
|
-0.73
|
0.37
|
0.00
|
--
|
|||||
|
Current Ratio
|
2.47
|
2.47
|
0.07
|
1.02
|
2.54
|
--
|
|||||
|
Quick Ratio
|
2.47
|
2.47
|
0.07
|
1.02
|
2.54
|
--
|
|||||
|
Interest Coverage
|
44.92
|
46.50
|
-36.92
|
-227.27
|
-28.15
|
--
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.43
|
0.44
|
22.37
|
20.56
|
13.70
|
--
|
|||||
|
Asset Turnover
|
1.52
|
1.50
|
0.17
|
0.11
|
0.29
|
--
|
|||||
|
Receivable days
|
--
|
2.36
|
80.33
|
116.55
|
50.01
|
--
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Payable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|